These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 29729815)

  • 41. Corrigendum to: Recent advances in the discovery of heparanase inhibitors as anti-cancer agents [Eur. J. Mech. 121 (2016) 209-220].
    Jia L; Ma S
    Eur J Med Chem; 2017 Jan; 125():793-794. PubMed ID: 27741490
    [No Abstract]   [Full Text] [Related]  

  • 42. Treatment response evaluation with
    Sachpekidis C; Hillengass J; Goldschmidt H; Wagner B; Haberkorn U; Kopka K; Dimitrakopoulou-Strauss A
    Eur J Nucl Med Mol Imaging; 2017 Jan; 44(1):50-62. PubMed ID: 27573638
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pathologic fractures in patients with multiple myeloma undergoing bisphosphonate therapy: incidence and correlation with course of disease.
    Vogel MN; Weisel K; Maksimovic O; Peters S; Brodoefel H; Claussen CD; Horger MS
    AJR Am J Roentgenol; 2009 Sep; 193(3):656-61. PubMed ID: 19696278
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Image interpretation criteria for FDG PET/CT in multiple myeloma: a new proposal from an Italian expert panel. IMPeTUs (Italian Myeloma criteria for PET USe).
    Nanni C; Zamagni E; Versari A; Chauvie S; Bianchi A; Rensi M; Bellò M; Rambaldi I; Gallamini A; Patriarca F; Gay F; Gamberi B; Cavo M; Fanti S
    Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):414-21. PubMed ID: 26475305
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Corrigendum to "Design, synthesis and evaluation of hybrid of tetrahydrocarbazole with 2,4-diaminopyrimidine scaffold as antibacterial agents" [Eur. J. Med. Chem. 162 (162) (2019) 203-211].
    Su L; Li J; Zhou Z; Huang D; Zhang Y; Pei H; Guo W; Wu H; Wang X; Liu M; Yang CG; Chen Y
    Eur J Med Chem; 2019 Apr; 168():385. PubMed ID: 30826513
    [No Abstract]   [Full Text] [Related]  

  • 46. F-18 FDG uptake of bone marrow on PET/CT scan: it's correlation with CD38/CD138 expressing myeloma cells in bone marrow of patients with multiple myeloma.
    Ak I; Gulbas Z
    Ann Hematol; 2011 Jan; 90(1):81-7. PubMed ID: 20690019
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Corrigendum to "Co-delivery of sorafenib and siVEGF based on mesoporous silica nanoparticles for ASGPR mediated targeted HCC therapy" [Eur. J. Pharm. Sci. 111 (1 January 2018) 492-502].
    Zheng G; Zhao R; Xu A; Shen Z; Chen X; Shao J
    Eur J Pharm Sci; 2018 Mar; 115():381. PubMed ID: 29395834
    [No Abstract]   [Full Text] [Related]  

  • 48. Corrigendum to "Discovery of novel nonsteroidal VDR agonists with novel diarylmethane skeleton for the treatment of breast cancer" [Eur. J. Med. Chem. 163 (2019) 787-803].
    Wang C; Wang B; Hou S; Xue L; Kang Z; Du J; Li Y; Liu X; Wang Q; Zhang C
    Eur J Med Chem; 2020 Jan; 186():111907. PubMed ID: 31791642
    [No Abstract]   [Full Text] [Related]  

  • 49. Corrigendum to '5-Aza-2'-deoxycytidine potentiates antitumor immune response induced by photodynamic therapy' [the Eur J Canc (2014) 1370-1381].
    Wachowska M; Gabrysiak M; Muchowicz A; Bednarek W; Barankiewicz J; Rygiel T; Boon L; Mroz P; Hamblin MR; Golab J
    Eur J Cancer; 2021 Jan; 142():150-151. PubMed ID: 33342466
    [No Abstract]   [Full Text] [Related]  

  • 50. Corrigendum to 'Optimal results immediately after MitraClip therapy or surgical edge-to-edge repair for functional mitral regurgitation: are they really stable at 4 years?' [Eur J Cardiothorac Surg 2016;50:488-494].
    De Bonis M; Lapenna E; Buzzatti N; La Canna G; Denti P; Pappalardo F; Schiavi D; Pozzoli A; Cioni M; Di Giannuario G; Alfieri O
    Eur J Cardiothorac Surg; 2017 Apr; 51(4):807. PubMed ID: 28380633
    [No Abstract]   [Full Text] [Related]  

  • 51. Corrigendum to 'What does the lay public know about heart failure? Findings from the Heart Failure Awareness Day Initiative'[Eur J Heart Fail 2016; 18:66-70].
    Eur J Heart Fail; 2016 Feb; 18(2):217. PubMed ID: 26861040
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Modern imaging techniques during therapy in patients with multiple myeloma.
    Horger M; Weisel K; Bares R; Ernemann U; Claussen CD; Lichy M; Fenchel M
    Acta Radiol; 2011 Oct; 52(8):881-8. PubMed ID: 21878551
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Survival of multiple myeloma patients aged 65-70 years in the era of novel agents and autologous stem cell transplantation. A multicenter retrospective collaborative study of the Japanese Society of Myeloma and the European Myeloma Network.
    Ozaki S; Harada T; Saitoh T; Shimazaki C; Itagaki M; Asaoku H; Kuroda Y; Chou T; Yoshiki Y; Suzuki K; Murakami H; Hayashi K; Mina R; Palumbo A; Shimizu K; ;
    Acta Haematol; 2014; 132(2):211-9. PubMed ID: 24662986
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term survival in a case of high-risk type IgD myeloma; a possibility of effectiveness of interferon-alpha and erythropoietin.
    Hiyoshi M; Hashimoto S; Ota T; Nakao T; Takubo T; Tagawa S; Tatsumi N
    Haematologia (Budap); 1997; 28(3):177-80. PubMed ID: 9283919
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Corrigendum to "Predicting and preventing thromboembolic events in patients receiving cisplatin-based chemotherapy for germ cell tumours" [Eur J Cancer 69 (2016) 151-157].
    Gizzi M; Oberic L; Massard C; Poterie A; Le Teuff G; Loriot Y; Albiges L; Baciarello G; Michels J; Bossi A; Blanchard P; Escudier B; Fizazi K
    Eur J Cancer; 2017 Apr; 75():333. PubMed ID: 28283351
    [No Abstract]   [Full Text] [Related]  

  • 56. Corrigendum to "Avoidable cancer cases in the Nordic countries - The impact of overweight and obesity" [Eur J Cancer 79 (2017) 106-118].
    Andersson TM; Weiderpass E; Engholm G; Lund AQ; Olafsdottir E; Pukkala E; Stenbeck M; Storm H
    Eur J Cancer; 2017 Dec; 87():219-220. PubMed ID: 29029964
    [No Abstract]   [Full Text] [Related]  

  • 57. Corrigendum to 'Dihydroorotate dehydrogenase: A drug target for the development of antimalarials' [Eur. J. Med. Chem. 125 (2017) 640-651].
    Singh A; Maqbool M; Mobashir M; Hoda N
    Eur J Med Chem; 2017 Mar; 128():346-347. PubMed ID: 28241929
    [No Abstract]   [Full Text] [Related]  

  • 58. Corrigendum to "Tumor suppression effects of myoepithelial cells on mice breast cancer" [Eur. J. Pharmacol. 765 (2015) 171-178].
    Farhangi B; Latifpour M; Alizadeh AM; Khodayari H; Khodayari S; Khaniki M; Ghasempour S
    Eur J Pharmacol; 2016 Jul; 782():119. PubMed ID: 27180042
    [No Abstract]   [Full Text] [Related]  

  • 59. Corrigendum to "Risk of Early Recurrent Stroke in Symptomatic Carotid Stenosis" [Eur J Vasc Endovasc Surg 49/2 (2015) 137-144].
    Strömberg S; Nordanstig A; Bentzel T; Österberg K; Bergström GML
    Eur J Vasc Endovasc Surg; 2017 Dec; 54(6):793. PubMed ID: 29032915
    [No Abstract]   [Full Text] [Related]  

  • 60. Corrigendum to "Cost-effectiveness analysis in melanoma detection: A transition model applied to dermoscopy" [Eur J Cancer 67 (2016) 38-45].
    Tromme I; Legrand C; Devleesschauwer B; Leiter U; Suciu S; Eggermont A; Sacré L; Baurain JF; Thomas L; Beutels P; Speybroeck N
    Eur J Cancer; 2017 Sep; 82():247. PubMed ID: 28662904
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.